Clinical Trials Logo

Magnetic Resonance Imaging clinical trials

View clinical trials related to Magnetic Resonance Imaging.

Filter by:

NCT ID: NCT03138837 Recruiting - Bladder Cancer Clinical Trials

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage

Start date: May 15, 2017
Phase: N/A
Study type: Observational

assess diagnostic performance of 3-Tesla DW-MRI in detecting and staging bladder cancer and potential role of the ADC value as a biomarker reflecting histological grade and stage.

NCT ID: NCT03044197 Completed - Prostate Cancer Clinical Trials

Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy

Start date: July 25, 2017
Phase: N/A
Study type: Interventional

Prostate biopsies are currently the gold standard for the diagnosis of prostate cancer. Many biopsies, however, are unnecessary or cannot detect significant prostate cancer (PCa). With multi-parametric magnetic resonance imaging (mpMRI) we now potentially have a way of increasing the detection of detecting clinically significant prostate cancer (csPCa) while decreasing the detection of non-significant PCa.

NCT ID: NCT03018158 Completed - Clinical trials for Magnetic Resonance Imaging

MR Images Variation With or Without Denture Wear

Start date: December 2016
Phase: N/A
Study type: Interventional

The objective of this study was to compare level of artifact while tongue at rest and in motion of dentulous subjects.

NCT ID: NCT03012763 Completed - Pharmacokinetics Clinical Trials

Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums

Start date: April 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine pharmacokinetics of the probe-drugs sulfasalazine, given in 240 ml non-caloric water and paracetamol, fexofenadine and valsartan after oral administration, given in 240 ml non-caloric water, in 240 ml caloric drink or in 240 ml grapefruit juice prior to ingestion and to visualize the localization and to measure the filling volume of stomach, small intestine as well as ascending, transverse and descending colon by T2-weighted magnetic resonance imaging after oral administration of 240 ml water (non-caloric water), after administration of 240 ml caloric drink and after administration of 240 ml grapefruit juice.

NCT ID: NCT02988531 Completed - Clinical trials for Coronary Artery Disease

Validation of PET-MRI for Cardiovascular Disease

Start date: February 9, 2017
Phase: N/A
Study type: Interventional

To determine whether PET-MRI can obtain comparable images to PET-CT in those with coronary artery disease.

NCT ID: NCT02980614 Recruiting - Clinical trials for Magnetic Resonance Imaging

4D Velocity Mapping of the Heart in rTOF Patients

CARDIOFLUX
Start date: March 27, 2017
Phase: N/A
Study type: Interventional

MRI with 4D flow permits to assess the hemodynamic parameters in a parent vessel and its branches inside the same sequence.

NCT ID: NCT02934776 Enrolling by invitation - Clinical trials for Magnetic Resonance Imaging

Prospective Cohort Study of the Ability of MRI/DTI to Diagnose Prostate Cancer

Start date: August 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to examine if investigators can improve diagnosis of prostate cancer by using MRI/DTI?

NCT ID: NCT02933190 Not yet recruiting - Clinical trials for Magnetic Resonance Imaging

Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy

Start date: November 2016
Phase: N/A
Study type: Interventional

To investigate the fertility in patients after treatment by transvaginal surgery or uterine artery embolization combined with uterine curettage

NCT ID: NCT02834585 Recruiting - Sarcoma Clinical Trials

Magnetic Resonance Imaging or Ultrasound in Soft Tissue Tumors (MUSTT)

MUSTT
Start date: October 2014
Phase: N/A
Study type: Observational

Adult soft tissue sarcomas (STS) are rare tumours with an estimated incidence averaging 5/100 000/year in Europe. The prognosis of soft tissue sarcomas is dominated by local recurrence and distant metastasis. A link seems to exist between local recurrence and overall survival. Local recurrence occurs in approximately 16-29% of STS of the limbs. A combination of resection and radiotherapy is the optimal treatment of primary tumours according to histological grade and surgical result. Modern imaging techniques such as ultrasound (US), magnetic resonance (MR) and computed tomography (CT) are normally used to rule-out a recurrence in patients operated on for STS. However, none of this technique is perfect and different advantages and drawbacks have to be considered in choosing one or another technique. In the past, US was used in tumour follow-up to detect tumour recurrences, however these studies didn't use high-resolution transducers and the timing of imaging respect to surgery was not defined. The recent advances in transducer technology improved the diagnostic capabilities of US. For the evaluation of limbs soft-tissue masses, US is widely used as a first level modality. The reasons are that US is widely available, fast, easily repeatable and often more accessible than CT and MR Imaging. In addition, US equipped with high-frequency transducers have a spatial resolution that may be comparable or higher than that of MR Imaging and CT in the evaluation of superficial soft-tissues. US and MR Imaging are often not able to differentiate benign from malignant tumours, therefore several lesions detected with US or MR Imaging warrant biopsy. The clinical practice guidelines of the ESMO (European Society of Medical Oncology) published in 2010 found that there are no published data to indicate the optimal routine follow-up policy of surgically treated patients with localized disease. Moreover, it has not been demonstrated that, for limb sarcomas recurrences, MR Imaging is superior and cost-effective compared to US for the assessment of the primary site. Considering that surgically treated intermediate-/high-grade patient may be followed frequently, even every 3-4 months in the first 2-3 years and considering that performing US is easier than having MR Imaging, the purpose of this study is to evaluate the diagnostic performance of US in the detection of local recurrences of adults patients with soft tissue sarcomas of the limb.

NCT ID: NCT02821078 Completed - Clinical trials for Magnetic Resonance Imaging

Evaluation of 4D Magnetic Resonance Flow Sequence at Hepatic Level

HEPAFLUX
Start date: March 16, 2017
Phase: N/A
Study type: Interventional

The objective of the project is to establish the 3D velocity mapping of the hepatic vasculature and its consistency